Icon

VITEKTA (nda203093)- (85MG,150MG)

ELVITEGRAVIR GILEAD SCIENCES INC
85MG,150MG
No No
2027-Apr-26 2017-Aug-27
None 2017-Sep-24
None No
VITEKTA is a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor used in combination with an HIV protease inhibitor coadministered with ritonavir and with other antiretroviral drug(s) indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults.
0 0 0
Total Other Developers None
Drugs with Suitability No
85MG ** ** - - -
150MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.